Long-Term Safety of Vedolizumab for IBD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Alimentary Pharmacology & Therapeutics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Safety of Vedolizumab for Inflammatory Bowel Disease
Aliment. Pharmacol. Ther. 2020 Sep 02;[EPub Ahead of Print], EV Loftus, BG Feagan, R Panaccione, JF Colombel, WJ Sandborn, BE Sands, S Danese, G D'Haens, DT Rubin, I Shafran, A Parfionovas, R Rogers, RA Lirio, S VermeireFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.